Search for other papers by Laura J Reid in
Google Scholar
PubMed
Search for other papers by Bala Muthukrishnan in
Google Scholar
PubMed
Search for other papers by Dilip Patel in
Google Scholar
PubMed
Search for other papers by Mike S Crane in
Google Scholar
PubMed
Search for other papers by Murat Akyol in
Google Scholar
PubMed
Search for other papers by Andrew Thomson in
Google Scholar
PubMed
Centre for Cardiovascular Science, Queen’s Medical Research Unit, University of Edinburgh, Edinburgh, UK
Search for other papers by Jonathan R Seckl in
Google Scholar
PubMed
Search for other papers by Fraser W Gibb in
Google Scholar
PubMed
undiagnosed as suggested by a recent study which identified measurement of parathyroid hormone (PTH) in only 31% of hypercalcaemic patients ( 4 ). In recent years, the normocalcaemic variant of PHPT has gained increasing recognition, although this is beyond
College of Medicine, Chang Gung University, Taoyuan, Taiwan
Search for other papers by Heng Yeh in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Hsuan Yeh in
Google Scholar
PubMed
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Chun-Cheng Chiang in
Google Scholar
PubMed
Search for other papers by Ju-Ching Yen in
Google Scholar
PubMed
Department of Nephrology, China Medical University Hospital, Taichung, Taiwan
Search for other papers by I-Kuan Wang in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Shou-Hsuan Liu in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Cheng-Chia Lee in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Cheng-Hao Weng in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Wen-Hung Huang in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Ching-Wei Hsu in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Tzung-Hai Yen in
Google Scholar
PubMed
Introduction Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD) characterized by the hypersecretion of parathyroid hormone (PTH) and the parathyroid gland hyperplasia stimulated by CKD-related chronic
Departament de Cirurgia, Universitat Autònoma de Barcelona, Barcelona, Spain
Search for other papers by Leyre Lorente-Poch in
Google Scholar
PubMed
Search for other papers by Sílvia Rifà-Terricabras in
Google Scholar
PubMed
Departament de Cirurgia, Universitat Autònoma de Barcelona, Barcelona, Spain
Search for other papers by Juan José Sancho in
Google Scholar
PubMed
Search for other papers by Danilo Torselli-Valladares in
Google Scholar
PubMed
Search for other papers by Sofia González-Ortiz in
Google Scholar
PubMed
Departament de Cirurgia, Universitat Autònoma de Barcelona, Barcelona, Spain
Search for other papers by Antonio Sitges-Serra in
Google Scholar
PubMed
Introduction Permanent hypoparathyroidism is a rare disorder characterized by low or inappropriately normal levels of parathyroid hormone leading to low calcium and increased phosphate serum levels ( 1 ). Immune-mediated destruction of the
Search for other papers by Weixi Wang in
Google Scholar
PubMed
Search for other papers by Rulai Han in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Jing Xie in
Google Scholar
PubMed
Search for other papers by Bei Tao in
Google Scholar
PubMed
Search for other papers by Fukang Sun in
Google Scholar
PubMed
Search for other papers by Ran Zhuo in
Google Scholar
PubMed
Search for other papers by Xi Chen in
Google Scholar
PubMed
Search for other papers by Xiaxing Deng in
Google Scholar
PubMed
Search for other papers by Cong Ye in
Google Scholar
PubMed
Search for other papers by Hongyan Zhao in
Google Scholar
PubMed
Search for other papers by Shu Wang in
Google Scholar
PubMed
patient IV:5 (D). Pedigree tree (E). Adrenal carcinoma, bilateral parathyroid adenoma and suspected pancreatic tumors suggested MEN1. MRI of pituitary disclosed microadenoma ( Fig. 1C ) with normal prolactin, growth hormone, thyroid
Search for other papers by Liubov G Yanevskaya in
Google Scholar
PubMed
First Pavlov State Medical University, St. Petersburg, Russia
Search for other papers by Tatiana Karonova in
Google Scholar
PubMed
Search for other papers by Ilya V Sleptsov in
Google Scholar
PubMed
Search for other papers by Marina Evgenevna Boriskova in
Google Scholar
PubMed
Search for other papers by Aluza Ramilevna Bakhtiyarova in
Google Scholar
PubMed
Search for other papers by Roman A Chernikov in
Google Scholar
PubMed
Search for other papers by Karina Aleksandrovna Pogosian in
Google Scholar
PubMed
Search for other papers by Alena Timurovna Andreeva in
Google Scholar
PubMed
Search for other papers by Denis Andreevich Lebedev in
Google Scholar
PubMed
First Pavlov State Medical University, St. Petersburg, Russia
Search for other papers by Elena Nikolaevna Grineva in
Google Scholar
PubMed
Search for other papers by John P Bilezikian in
Google Scholar
PubMed
Introduction Primary hyperparathyroidism (PHPT) is a disease characterized by excessive synthesis and secretion of parathyroid hormone (PTH) from one or more of the four parathyroid glands ( 1 ). Most patients present with hypercalcemia though
Search for other papers by Maria Angela D'amico in
Google Scholar
PubMed
Search for other papers by Barbara Ghinassi in
Google Scholar
PubMed
Search for other papers by Pascal Izzicupo in
Google Scholar
PubMed
Search for other papers by Lamberto Manzoli in
Google Scholar
PubMed
Search for other papers by A Di Baldassarre in
Google Scholar
PubMed
neuroendocrine differentiation. Its name is derived from the original discovery in adrenal medulla (2) . CgA is co-stored and co-released with catecholamines from storage granules in the adrenal medulla, or with the parathyroid hormone in response to
The University of Warwick, Coventry, UK
Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Search for other papers by Sharon A Huish in
Google Scholar
PubMed
Search for other papers by Carl Jenkinson in
Google Scholar
PubMed
Search for other papers by Janet A Dunn in
Google Scholar
PubMed
Search for other papers by David J Meredith in
Google Scholar
PubMed
Search for other papers by Rosemary Bland in
Google Scholar
PubMed
Search for other papers by Martin Hewison in
Google Scholar
PubMed
), is expressed primarily in the renal proximal tubule ( 1 , 2 ), and is positively and negatively regulated by parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), respectively ( 3 ). While the kidney has a central role in 1,25(OH) 2 D
Search for other papers by Stan Ursem in
Google Scholar
PubMed
Search for other papers by Vito Francic in
Google Scholar
PubMed
Search for other papers by Martin Keppel in
Google Scholar
PubMed
Search for other papers by Verena Schwetz in
Google Scholar
PubMed
Search for other papers by Christian Trummer in
Google Scholar
PubMed
Search for other papers by Marlene Pandis in
Google Scholar
PubMed
Search for other papers by Felix Aberer in
Google Scholar
PubMed
Search for other papers by Martin R Grübler in
Google Scholar
PubMed
Search for other papers by Nicolas D Verheyen in
Google Scholar
PubMed
Search for other papers by Winfried März in
Google Scholar
PubMed
Search for other papers by Andreas Tomaschitz in
Google Scholar
PubMed
Search for other papers by Stefan Pilz in
Google Scholar
PubMed
Search for other papers by Barbara Obermayer-Pietsch in
Google Scholar
PubMed
Department of Clinical Chemistry, Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam, Endocrine Laboratory, Amsterdam, Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Introduction Parathyroid hormone (PTH) plays a critical role in maintaining adequate serum calcium homeostasis. It increases serum calcium by stimulating bone resorption, promoting phosphate excretion, converting vitamin D to its active form
Search for other papers by Göran Oleröd in
Google Scholar
PubMed
Search for other papers by Lillemor Mattsson Hultén in
Google Scholar
PubMed
Search for other papers by Ola Hammarsten in
Google Scholar
PubMed
Search for other papers by Eva Klingberg in
Google Scholar
PubMed
be used as LoQ. Serum intact parathyroid hormone (iPTH) was analyzed with CLIA on an Abbott ARCHITECT instrument (Abbott Diagnostics Division) and serum 1,25(OH) 2 D was analyzed on an IDS-iSYS instrument (Immunodiagnostic Systems Holdings, Boldon
Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
parathyroid hormone (PTH) has been described in several case reports ( 52 , 53 ). ICPI-induced hypoparathyroidism differs mechanistically from the other endocrine irAEs. Activating autoantibodies against the calcium-sensing receptor disrupt the glands